Simona Colantonio

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

Methods to Make Homogenous Antibody Drug Conjugates

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

Pyroptosis: mechanisms and diseases

Strategies and challenges for the next generation of antibody–drug conjugates

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer

RP-HPLC DAR Characterization of Site-Specific Antibody Drug Conjugates Produced in a Cell-Free Expression System

Optimal Synthetic Glycosylation of a Therapeutic Antibody

Antibody Conjugates: From Heterogeneous Populations to Defined Reagents

Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases

Immunotoxins for leukemia

Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody–Drug Conjugates

Industry sponsorship and research outcome

Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar

A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene

Pharmacokinetics of Gemcitabine at Fixed-Dose Rate Infusion in Patients with Normal and Impaired Hepatic Function